1 2 3 4 5 6
Newlystar was founded on Sep, 2007. From the day of founding, we are dedicated to building a good platform for pharma trading which combined China facilities and global pharmaceutical distributors.Newlystar is very professional in quality management, GMP auditing, regulative affairs and business development, and we are willing to help our cooperative facilities to solve above mentioned barrier in formulation trading and develop international market together.
With the combined efforts, Newlystar has more than 10 cooperative facilities passed various GMP auditing from abroad, include INVIMA (Colombia), Peru, Anvisa (Brazil), TGA (Austrilia), Germany etc. And their products enter local market through Newlystar’s clients.
Now, our exportation markets already cover East European countries, Latin American countries, Central and southeast Asian countries, middle east and African. With the update of GMP system, we will have more and more facilities passing GMP auditing from US FDA, EMA, Contract manufacturing for European Pharmaceutical companies will take much larger partition in Newlystar’s total business.
From the year 2011, our turnover already exceeded 20 million USD on formulations. And the number keeps rising quickly these years.